Jupiter Wellness, Inc. (JUPW)

NASDAQ: JUPW · IEX Real-Time Price · USD
0.641
+0.011 (1.78%)
At close: Aug 17, 2022 4:00 PM
0.660
+0.019 (2.932%)
After-hours: Aug 17, 2022 6:37 PM EDT
1.78%
Market Cap 14.07M
Revenue (ttm) 3.55M
Net Income (ttm) -28.82M
Shares Out 21.94M
EPS (ttm) -1.47
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 37,658
Open 0.630
Previous Close 0.630
Day's Range 0.626 - 0.650
52-Week Range 0.590 - 2.240
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About JUPW

Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the ... [Read more...]

Industry Drug Manufacturers-Specialty & Generic
IPO Date Oct 30, 2020
Employees 12
Stock Exchange NASDAQ
Ticker Symbol JUPW
Full Company Profile

Financial Performance

In 2021, JUPW's revenue was $2.88 million, an increase of 169.90% compared to the previous year's $1.07 million. Losses were -$28.10 million, 346.8% more than in 2020.

Financial Statements

News

SRM Entertainment Announces Licensing Agreement with Toonz Media Group and Zoonicorn LLC for Pre-School Brand Zoonicorn

New Zoonicorn Branded Consumer Products From SRM Entertainment to Be Available Beginning Fall, 2022 JUPITER, FL / ACCESSWIRE / August 17, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that...

Jupiter Wellness Reports Second Quarter 2022 Financial Results and Operational Highlights

Minoxidil Booster Licensed to Taisho Pharmaceutical for the Japanese Market No Stingz Jellyfish Protectant SPF Sunscreen Launched $3,000,582 in Revenues for the Three Months Ended June 30, 2022 JUPITER,...

SRM Entertainment Announces Multi-Year SMURFS License

Smurfs brand and characters to be featured on custom "Sip With Me" Product Lines JUPITER, FL / ACCESSWIRE / August 11, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that its SRM Entertainm...

Jupiter Wellness Announces Repayment Agreement with Benuvia, Inc., Formally Next Frontier Pharmaceuticals

Benuvia Agrees to Pay $3 MM and Issue Capital Stock Representing 8.0% of their previously announced SPAC merger with Pono Capital Corp JUPITER, FL / ACCESSWIRE / July 26, 2022 / Jupiter Wellness, Inc. (...

Jupiter Wellness Expands Distribution in Asia and the Middle East with Newly Acquired Minoxidil (Rogaine(R)) and Phot...

Jupiter receives upfront payment plus double-digit royalties on revenues in 31 countries for clinically proven minoxidil (Rogaine®) products Minoxidil Booster and After Minoxidil Spray, and Photoci, a p...

Jupiter Wellness Licenses Minoxidil Booster to Taisho

Taisho to introduce a minoxidil booster developed by Applied Biology to boost minoxidil efficacy for Androgenetic Alopecia patients that do not respond to minoxidil The minoxidil sulfotransferase enzyme...

Dr. Andy Goren and Dr. John McCoy Appointed to Senior Scientific Positions at Jupiter Wellness

JUPITER, FL / ACCESSWIRE / June 22, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that Prof. Andy Goren, MD, and John McCoy, PhD have joined Jupiter Wellness as Chief Medical Officer and V...

Jupiter Wellness Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair an...

Assets include issued patents, patent applications, products, clinical trial results, licensing agreements Applied Biology generated approximately $8 million in revenues and $3 million in EBITDA in 2021...

Jupiter Wellness Announces the Retirement of Approximately 10% of its Outstanding Shares

JUPITER, FL / ACCESSWIRE / June 17, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced the purchase and retirement of 2,433,894 common shares, which reduces the Company's outstanding common sha...

Paul Jones Appointed as Senior Project Manager at Jupiter Wellness

JUPITER, FL / ACCESSWIRE / June 2, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that Paul Jones has joined Jupiter Wellness as Senior Project Manager. Paul joins Jupiter Wellness with ove...

Jupiter Wellness' to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medica...

JW-300 Demonstrated Efficacy in the Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo-Controlled Clinical Trial JUPITER, FL / ACCESSWIRE / May 4, 2022 / Jupiter Wellness, Inc. (NASDAQ:...

Jupiter Wellness to Offer Clinical Research Services with Acquisition of Ascent Clinical Research: $3 Million Annual ...

IN A BID TO EXPAND JUPITER WELLNESS'S RESEARCH CAPABILITIES AND ENTER THE LUCRATIVE CRO BUSINESS, JUPITER WELLNESS ACQUIRED THE ASSETS OF ASCENT CLINICAL RESEARCH JUPITER, FL / ACCESSWIRE / April 27, 20...

Jupiter Wellness Appoints E-Commerce & Marketing Team to Drive Sales of its Growing Portfolio of Proprietary Health a...

JUPITER, FL / ACCESSWIRE / April 18, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that it has appointed three sales and marketing executives to its team to drive sales of its science-back...

Jupiter Wellness to Launch CaniSun for Shark Defense Sunscreen with Patented Shark Repellents

Exclusive Worldwide Rights to Patented Shark Repellent Technologies for the Sun and Skin Market Licensed From Shark Defense Technologies, the Leader in Its Field Featured in Numerous Media Outlets Inclu...

Article "Novel Cannabidiol Aspartame Combination Treatment (JW-100) Significantly Reduces ISGA Score in Atopic Dermat...

Authored by an International Group of Leading Dermatology Researchers and Clinicians Who Conducted the Studies JUPITER, FL / ACCESSWIRE / April 6, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today anno...

Jupiter Wellness Completes Enrollment in Double-Blind Placebo-Controlled Clinical Trial of JW-200 for the Treatment o...

Data expected Q1 2022 on efficacy of JW-200 to clear AK lesions, a common form of pre-cancerous growth that left untreated can lead to cancer in up to 15% of patients JUPITER, FL / ACCESSWIRE / February...

Jupiter Wellness Merger Partner Next Frontier's Executive Chairman Shannon Soqui Interview with Benzinga

JUPITER, FL / ACCESSWIRE / February 15, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW) today announced that its merger partner Next Frontier Pharmaceuticals' Executive Chairman Shannon Soqui was interviewe...

Jupiter Wellness' CEO Brian John & Next Frontier's Executive Chairman Shannon Soqui Interviewed on SNN Network

Corporate Presentation Highlights Merged Company's Strength as Leading Drug Developer Focused on Pharma Cannabinoids: LINK JUPITER, FL / ACCESSWIRE / February 2, 2022 / Jupiter Wellness, Inc. (NASDAQ:JU...

Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Announces Plans for Oral Dronabinol Solution for...

Next Frontier Pharmaceuticals is pursuing FDA 505(b)(2) fast-track approval with its previously FDA approved oral dronabinol (THC) solution Next Frontier Pharmaceuticals has completed a pre-IND meeting ...

Jupiter Wellness Announces Board Approval of $5.0 Million Share Buyback Program

Represents Approximately 30% of Jupiter Wellness's Outstanding Shares at current market price JUPITER, FL / ACCESSWIRE / January 25, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it its bo...

Jupiter Wellness To Dividend SRM Entertainment Subsidiary To Its Stockholders.

Jupiter Wellness, Inc. (NASDAQ:JUPW) revealed plans Monday to dividend its wholly-owned subsidiary, SRM Entertainment to its stockholders with Jupiter's merger with Next Frontier Pharmaceuticals, Inc. E...

Jupiter Wellness to Dividend SRM Entertainment Subsidiary to its Stockholders

SRM Entertainment to raise up to $10 million and seek listing on Nasdaq Creates a "Pure Play" Drug Developer in Jupiter Wellness upon the Completion of its Pending Merger with Next Frontier Pharmaceutic...

Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development and API Market

Next Frontier Pharmaceuticals' Subsidiary Benuvia Signs Agreement with Global Wellness' Shanti Therapeutics Benuvia has begun focusing on Psilocybin, DMT, and MDMA. Benuvia's 83,000 square foot syntheti...

JUPITER WELLNESS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merg...

NEW ORLEANS, Jan. 4, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Jupiter Wellness, Inc.

NEW YORK, Dec. 14, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Jupiter Wellness, Inc. ("Jupiter" or th...